Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin54.8%+1.3pp53.5%+2.1pp51.4%-8.0pp59.4%+0.9pp58.5%-1.5pp
Efficiency
Asset turnover0.0×-0.1×+0.1×0.9×0.0×0.8×+0.1×
Liquidity
Current ratio1.2×-0.4×1.6×-0.1×1.6×-0.1×1.8×-0.2×-0.1×
Leverage
Debt-to-equity-0.2×1.2×-0.1×1.3×+0.1×1.3×0.0×1.2×0.0×
Valuation
Market capitalization$930.79M+162%$453.48M-22.2%$582.75M+59.9%$364.45M+4.7%$348.09M+0.3%
Price / sales10.7×+3.4×5.7×-2.6×8.3×+2.0×6.3×-0.9×7.2×-1.7×
Price / book31.2×+16.3×17.3×-7.9×25.2×+10.0×15.2×+1.0×14.2×0.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Eton Pharmaceuticals, Inc.'s profit margins?
Eton Pharmaceuticals, Inc. (ETON) runs a 54.8% gross margin and a -15.1% operating margin, with a -9.5% net margin.
Where do Eton Pharmaceuticals, Inc.'s ratios come from?
Every ratio is computed from Eton Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.